News
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
An FDA deadline instructing compounding pharmacies and telehealth companies to stop selling compounded versions of Ozempic and Zepbound has not stopped the copycat market, The Wall Street Journal ...
Ozempic maker Novo Nordisk NOVO.B-1.81%decrease; red down pointing triangle pushed out its chief executive after losing ground in the anti-obesity drug market, which has caused a steep stock-price ...
Carnie Wilson will not be turning to Ozempic for weight loss anytime soon. During an interview with Fox News Digital, Wilson, who previously lost more than 100 pounds with gastric bypass and lap ...
In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the company. The Danish pharmaceutical giant announced Friday that ...
“I’m not on Ozempic. I’m not sick. I didn’t get a face transplant. And no, I didn’t get a brow lift.” As she removed her makeup, the 41-year-old expressed dismay at the personal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results